Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
19.6M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
1.14M
-
Shares change
-
-144K
-
Total reported value, excl. options
-
$36.2M
-
Value change
-
-$24.7M
-
Number of buys
-
20
-
Number of sells
-
-38
-
Price
-
$31.74
Significant Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) as of Q3 2021
64 filings reported holding ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.14M shares
of 19.6M outstanding shares and own 5.82% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (229K shares), VOLORIDGE INVESTMENT MANAGEMENT, LLC (109K shares), BlackRock Inc. (103K shares), TWO SIGMA INVESTMENTS, LP (97.6K shares), AIGH Capital Management LLC (66.5K shares), MILLENNIUM MANAGEMENT LLC (65.6K shares), Wescott Financial Advisory Group, LLC (41.6K shares), GEODE CAPITAL MANAGEMENT, LLC (40.9K shares), MORGAN STANLEY (38K shares), and CITADEL ADVISORS LLC (37.2K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.